IRIS
Patti, Giuseppe Rocco Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.245
NA - Nord America 3.162
AS - Asia 922
SA - Sud America 22
OC - Oceania 8
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.366
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.134
IE - Irlanda 2.314
UA - Ucraina 639
SE - Svezia 458
IT - Italia 452
SG - Singapore 341
HK - Hong Kong 244
CN - Cina 205
DE - Germania 186
CZ - Repubblica Ceca 73
FR - Francia 39
IN - India 39
IR - Iran 31
CA - Canada 28
NL - Olanda 18
BE - Belgio 14
GB - Regno Unito 11
FI - Finlandia 10
JP - Giappone 10
PK - Pakistan 9
AU - Australia 8
PE - Perù 8
VN - Vietnam 8
KR - Corea 7
MY - Malesia 7
RU - Federazione Russa 7
BR - Brasile 6
CH - Svizzera 4
MO - Macao, regione amministrativa speciale della Cina 4
PH - Filippine 4
TH - Thailandia 4
TR - Turchia 4
CL - Cile 3
ES - Italia 3
GR - Grecia 3
LT - Lituania 3
PL - Polonia 3
VE - Venezuela 3
AR - Argentina 2
EU - Europa 2
LI - Liechtenstein 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
BD - Bangladesh 1
EG - Egitto 1
KE - Kenya 1
KH - Cambogia 1
MK - Macedonia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SN - Senegal 1
Totale 8.366
Salva come PNG Salva come JPEG
Città #
Dublin 2.270
Jacksonville 1.250
Lawrence 281
Princeton 281
Wilmington 279
Hong Kong 233
Singapore 192
Beijing 173
Ashburn 106
Chandler 82
Brno 72
San Mateo 62
Ann Arbor 55
Milan 51
Bremen 48
Piemonte 38
Munich 32
Mülheim 32
Novara 31
Norwalk 26
Turin 26
Houston 24
Vercelli 23
Fairfield 21
Torino 20
West Jordan 20
Boardman 19
Menlo Park 15
Andover 14
Brussels 14
Woodbridge 13
Toronto 12
Chennai 11
Monmouth Junction 11
Amsterdam 9
Ardabil 9
Helsinki 9
Zanjan 9
Des Moines 8
Lancenigo-Villorba 8
Montreal 8
Nanjing 8
Rome 7
Seattle 7
Sham Shui Po 7
Sydney 7
Augusta 6
Eindhoven 6
Leipzig 6
New York 6
Philadelphia 6
Strasbourg 6
Alessandria 5
Cassano Magnago 5
Chimbote 5
Frankfurt am Main 5
Grafing 5
Naples 5
Palermo 5
Paris 5
Hefei 4
Macao 4
Odalengo Grande 4
Oleggio 4
Redwood City 4
Senigallia 4
Shanghai 4
Tehran 4
Tokyo 4
Athens 3
Bad Homburg 3
Bangalore 3
Bangkok 3
Berlin 3
Bien Hoa 3
Binasco 3
Breda 3
Busanjin-gu 3
Cambridge 3
Fremont 3
Garden City 3
Goyang-si 3
Greenville 3
Guangzhou 3
Ho Chi Minh City 3
Ipoh 3
Jinan 3
Leawood 3
Lima 3
Mumbai 3
Pioltello 3
Pune 3
Rennes 3
Santa Clara 3
Sialkot 3
St Petersburg 3
Surat 3
Temuco 3
Valencia 3
Vancouver 3
Totale 6.138
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 219
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 141
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 99
Change over time of COVID-19 hospital presentation in Northern Italy 93
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 89
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 72
One-Year Follow up of Noninvasive Respiratory Support in General Wards 66
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 66
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 63
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 62
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 53
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 51
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 48
Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases 47
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 46
Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis 45
Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention 43
Metabolomics diagnosis of covid-19 from exhaled breath condensate 42
Safety and Efficacy of Different Antithrombotic Strategies After Transcatheter Aortic Valve Implantation: A Network Meta-Analysis 41
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 40
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease 39
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 39
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 39
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 38
Causes of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: findings from the SYNCOPACED registry 38
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 38
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 37
Percutaneous coronary interventions and statin therapy 37
Clinical benefits of statin pretreatment in patients undergoing coronary revascularization 37
Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome 36
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 36
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 36
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 36
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study 35
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 35
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 35
A clinical-in silico study on the effectiveness of multipoint bicathodic and cathodic-anodal pacing in cardiac resynchronization therapy 35
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 34
Are we ready for a gender-specific approach in interventional cardiology? 34
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 34
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 34
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 34
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 34
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak 34
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 33
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 33
Apoptosis in recent myocardial infarction 33
Infective endocarditis complicating COVID-19 pneumonia: a case report 33
Clustering of blood cell count abnormalities and future risk of death 33
Prevention of ischaemic events in subjects with polydistrict vascular disease 33
Usefulness of a multiparametric evaluation including global longitudinal strain for an early diagnosis of acute myocarditis 33
[Zero-fluoroscopy transcatheter ablation and CRT-D implantation: new frontiers of electroanatomical mapping systems] 32
Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease 32
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 32
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 32
Atorvastatin for reduction of myocardial damage during angioplasty trials 32
Chapter "Chronobiology of the haemostatic system", for the book “Physiology and pharmacology of biological rhythms” (Editors P. H. Redfern e B. Lemmer) (Springer) 32
Speckle Tracking Echocardiography: Early Predictor of Diagnosis and Prognosis in Coronary Artery Disease 32
Terapie antitrombotiche in pazienti con infezione da SARS-CoV-2: Dalle attuali evidenze alle ragionevoli raccomandazioni – Position paper del gruppo di studio aterosclerosi, trombosi e biologia vascolare 32
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study) 31
Association of virulent Helicobacter pylori strains with ischemic heart disease 31
Myocardial infarction during pregnancy and postpartum: A review 31
Monacolin Product Monograph (Springer Healthcare) 31
Risk of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: Role of correlation between symptoms and electrocardiogram findings 31
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 31
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 31
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry 31
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study * 31
Statin loading for acute coronary syndromes 30
Influence of Platelet Reactivity on Outcome of Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty 30
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 30
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention - Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study 30
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 30
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 30
Uric acid and contrast-induced nephropathy: An updated review and meta-regression analysis 30
Primum non nocere does not justify clinical inertia for stroke prevention in elderly patients with atrial fibrillation in the era of direct oral anticoagulants 30
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 30
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak 30
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 29
Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients 29
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 29
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment 29
Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke 29
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 29
Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation 29
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 29
Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass 29
Secondary cardiovascular prevention after acute coronary syndrome in clinical practice 29
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 29
Point-of-Care Assessment of Platelet Reactivity After Clopidogrel to Predict Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention 29
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study 29
Management of patients explanted for implantable cardioverter defibrillator infections: Bridge therapy with external temporary ICD 28
Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status 28
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 28
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery - Results of the ARMYDA-3 (Atorvastatin for reduction of MYocardial dysrhythmia after cardiac surgery) study 28
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study) 28
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 28
Coronary stenting in patients with depressed left ventricular function: Acute and long-term results in a selected population 28
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 28
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 28
Totale 3.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.051 0 0 2 0 2 10 437 10 203 178 209 0
2020/20211.686 197 0 197 2 212 29 477 15 247 31 264 15
2021/20221.266 56 34 64 91 72 22 43 49 147 72 242 374
2022/20233.291 327 108 144 30 93 127 79 98 2.083 22 133 47
2023/20241.577 78 79 80 45 307 38 217 63 68 77 100 425
2024/2025124 102 22 0 0 0 0 0 0 0 0 0 0
Totale 9.003